nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—HTR7—Parkinson's disease	0.139	0.191	CbGaD
Ziprasidone—DRD3—Parkinson's disease	0.13	0.179	CbGaD
Ziprasidone—DRD1—Parkinson's disease	0.128	0.176	CbGaD
Ziprasidone—HTR1A—Parkinson's disease	0.106	0.146	CbGaD
Ziprasidone—DRD2—Parkinson's disease	0.0903	0.124	CbGaD
Ziprasidone—HTR2A—Parkinson's disease	0.0698	0.0959	CbGaD
Ziprasidone—CYP2D6—Parkinson's disease	0.0638	0.0877	CbGaD
Ziprasidone—HTR3A—enteric nervous system—Parkinson's disease	0.00561	0.0528	CbGeAlD
Ziprasidone—HTR3A—myenteric nerve plexus—Parkinson's disease	0.00425	0.04	CbGeAlD
Ziprasidone—HTR7—enteric nervous system—Parkinson's disease	0.00363	0.0342	CbGeAlD
Ziprasidone—HTR7—superior cervical ganglion—Parkinson's disease	0.00347	0.0327	CbGeAlD
Ziprasidone—HTR7—myenteric nerve plexus—Parkinson's disease	0.00275	0.0259	CbGeAlD
Ziprasidone—DRD3—telencephalic ventricle—Parkinson's disease	0.00254	0.0239	CbGeAlD
Ziprasidone—HTR7—locus ceruleus—Parkinson's disease	0.0024	0.0226	CbGeAlD
Ziprasidone—HTR2A—enteric nervous system—Parkinson's disease	0.00226	0.0213	CbGeAlD
Ziprasidone—HTR7—sympathetic nervous system—Parkinson's disease	0.00189	0.0178	CbGeAlD
Ziprasidone—DRD1—telencephalic ventricle—Parkinson's disease	0.00182	0.0171	CbGeAlD
Ziprasidone—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00172	0.0162	CbGeAlD
Ziprasidone—HTR2A—locus ceruleus—Parkinson's disease	0.00149	0.0141	CbGeAlD
Ziprasidone—HTR1B—telencephalic ventricle—Parkinson's disease	0.00147	0.0139	CbGeAlD
Ziprasidone—HTR1D—telencephalic ventricle—Parkinson's disease	0.00143	0.0134	CbGeAlD
Ziprasidone—HTR2C—telencephalic ventricle—Parkinson's disease	0.00141	0.0133	CbGeAlD
Ziprasidone—HTR7—pons—Parkinson's disease	0.00138	0.013	CbGeAlD
Ziprasidone—HTR7—autonomic nervous system—Parkinson's disease	0.00127	0.012	CbGeAlD
Ziprasidone—Lurasidone—HTR7—Parkinson's disease	0.00127	0.181	CrCbGaD
Ziprasidone—HTR2A—cerebellar cortex—Parkinson's disease	0.00122	0.0115	CbGeAlD
Ziprasidone—HTR1A—telencephalic ventricle—Parkinson's disease	0.00119	0.0112	CbGeAlD
Ziprasidone—HTR2A—sympathetic nervous system—Parkinson's disease	0.00118	0.0111	CbGeAlD
Ziprasidone—DRD1—nerve—Parkinson's disease	0.00115	0.0108	CbGeAlD
Ziprasidone—HTR7—telencephalic ventricle—Parkinson's disease	0.00114	0.0107	CbGeAlD
Ziprasidone—HTR3A—nerve—Parkinson's disease	0.00111	0.0104	CbGeAlD
Ziprasidone—DRD2—telencephalic ventricle—Parkinson's disease	0.00107	0.0101	CbGeAlD
Ziprasidone—Lurasidone—HTR1A—Parkinson's disease	0.000974	0.139	CrCbGaD
Ziprasidone—HTR7—peripheral nervous system—Parkinson's disease	0.000919	0.00865	CbGeAlD
Ziprasidone—HTR2A—pons—Parkinson's disease	0.000861	0.00811	CbGeAlD
Ziprasidone—HTR1E—brainstem—Parkinson's disease	0.000843	0.00794	CbGeAlD
Ziprasidone—Lurasidone—DRD2—Parkinson's disease	0.000827	0.118	CrCbGaD
Ziprasidone—HTR1E—forebrain—Parkinson's disease	0.000813	0.00766	CbGeAlD
Ziprasidone—HTR2A—autonomic nervous system—Parkinson's disease	0.000794	0.00748	CbGeAlD
Ziprasidone—HTR7—nerve—Parkinson's disease	0.000716	0.00675	CbGeAlD
Ziprasidone—HTR2A—telencephalic ventricle—Parkinson's disease	0.000708	0.00667	CbGeAlD
Ziprasidone—DRD2—nerve—Parkinson's disease	0.000677	0.00638	CbGeAlD
Ziprasidone—ADRA2A—peripheral nervous system—Parkinson's disease	0.000674	0.00635	CbGeAlD
Ziprasidone—Lurasidone—HTR2A—Parkinson's disease	0.000639	0.0909	CrCbGaD
Ziprasidone—HTR6—forebrain—Parkinson's disease	0.000638	0.00601	CbGeAlD
Ziprasidone—SLC6A4—hindbrain—Parkinson's disease	0.000632	0.00595	CbGeAlD
Ziprasidone—DRD5—forebrain—Parkinson's disease	0.000621	0.00585	CbGeAlD
Ziprasidone—HTR2A—peripheral nervous system—Parkinson's disease	0.000573	0.0054	CbGeAlD
Ziprasidone—HTR1A—hindbrain—Parkinson's disease	0.000561	0.00529	CbGeAlD
Ziprasidone—H1F0—embryo—Parkinson's disease	0.000544	0.00512	CbGeAlD
Ziprasidone—HTR7—hindbrain—Parkinson's disease	0.000536	0.00505	CbGeAlD
Ziprasidone—ADRA1A—hindbrain—Parkinson's disease	0.000517	0.00487	CbGeAlD
Ziprasidone—DRD2—hindbrain—Parkinson's disease	0.000507	0.00478	CbGeAlD
Ziprasidone—DRD1—brainstem—Parkinson's disease	0.000492	0.00463	CbGeAlD
Ziprasidone—H1F0—forebrain—Parkinson's disease	0.000481	0.00453	CbGeAlD
Ziprasidone—HTR3A—brainstem—Parkinson's disease	0.000475	0.00448	CbGeAlD
Ziprasidone—DRD1—forebrain—Parkinson's disease	0.000475	0.00447	CbGeAlD
Ziprasidone—HTR1E—head—Parkinson's disease	0.000466	0.00439	CbGeAlD
Ziprasidone—HTR3A—forebrain—Parkinson's disease	0.000459	0.00432	CbGeAlD
Ziprasidone—HTR2A—nerve—Parkinson's disease	0.000447	0.00421	CbGeAlD
Ziprasidone—HTR1E—nervous system—Parkinson's disease	0.000442	0.00416	CbGeAlD
Ziprasidone—HTR1E—central nervous system—Parkinson's disease	0.000425	0.004	CbGeAlD
Ziprasidone—CHRM4—head—Parkinson's disease	0.000408	0.00385	CbGeAlD
Ziprasidone—H1F0—cardiovascular system—Parkinson's disease	0.000407	0.00383	CbGeAlD
Ziprasidone—HTR1B—brainstem—Parkinson's disease	0.000399	0.00375	CbGeAlD
Ziprasidone—DRD4—brain—Parkinson's disease	0.000391	0.00369	CbGeAlD
Ziprasidone—CHRM4—nervous system—Parkinson's disease	0.000387	0.00365	CbGeAlD
Ziprasidone—HTR1D—brainstem—Parkinson's disease	0.000386	0.00364	CbGeAlD
Ziprasidone—HTR1B—forebrain—Parkinson's disease	0.000385	0.00362	CbGeAlD
Ziprasidone—CHRM2—forebrain—Parkinson's disease	0.000383	0.0036	CbGeAlD
Ziprasidone—HTR2C—brainstem—Parkinson's disease	0.000382	0.0036	CbGeAlD
Ziprasidone—DRD3—head—Parkinson's disease	0.00038	0.00358	CbGeAlD
Ziprasidone—CHRM4—central nervous system—Parkinson's disease	0.000373	0.00351	CbGeAlD
Ziprasidone—HTR1D—forebrain—Parkinson's disease	0.000372	0.00351	CbGeAlD
Ziprasidone—HTR2C—forebrain—Parkinson's disease	0.000369	0.00347	CbGeAlD
Ziprasidone—HTR6—head—Parkinson's disease	0.000365	0.00344	CbGeAlD
Ziprasidone—SLC6A4—brainstem—Parkinson's disease	0.000362	0.00341	CbGeAlD
Ziprasidone—DRD3—nervous system—Parkinson's disease	0.00036	0.00339	CbGeAlD
Ziprasidone—DRD5—head—Parkinson's disease	0.000356	0.00335	CbGeAlD
Ziprasidone—SLC6A4—forebrain—Parkinson's disease	0.00035	0.00329	CbGeAlD
Ziprasidone—CHRM1—forebrain—Parkinson's disease	0.000348	0.00328	CbGeAlD
Ziprasidone—H1F0—medulla oblongata—Parkinson's disease	0.000347	0.00327	CbGeAlD
Ziprasidone—DRD3—central nervous system—Parkinson's disease	0.000347	0.00326	CbGeAlD
Ziprasidone—HTR6—nervous system—Parkinson's disease	0.000346	0.00326	CbGeAlD
Ziprasidone—HTR1E—brain—Parkinson's disease	0.000338	0.00318	CbGeAlD
Ziprasidone—DRD5—nervous system—Parkinson's disease	0.000337	0.00318	CbGeAlD
Ziprasidone—HTR2A—hindbrain—Parkinson's disease	0.000334	0.00315	CbGeAlD
Ziprasidone—HTR6—central nervous system—Parkinson's disease	0.000334	0.00314	CbGeAlD
Ziprasidone—HTR1B—cardiovascular system—Parkinson's disease	0.000325	0.00306	CbGeAlD
Ziprasidone—DRD5—central nervous system—Parkinson's disease	0.000325	0.00306	CbGeAlD
Ziprasidone—CHRM2—cardiovascular system—Parkinson's disease	0.000324	0.00305	CbGeAlD
Ziprasidone—HTR1A—brainstem—Parkinson's disease	0.000322	0.00303	CbGeAlD
Ziprasidone—CHRM5—head—Parkinson's disease	0.000319	0.00301	CbGeAlD
Ziprasidone—H1F0—midbrain—Parkinson's disease	0.000318	0.00299	CbGeAlD
Ziprasidone—HTR1D—cardiovascular system—Parkinson's disease	0.000315	0.00297	CbGeAlD
Ziprasidone—DRD1—midbrain—Parkinson's disease	0.000314	0.00295	CbGeAlD
Ziprasidone—CHRM3—forebrain—Parkinson's disease	0.000312	0.00294	CbGeAlD
Ziprasidone—HTR1A—forebrain—Parkinson's disease	0.00031	0.00292	CbGeAlD
Ziprasidone—H1F0—spinal cord—Parkinson's disease	0.00031	0.00292	CbGeAlD
Ziprasidone—HTR7—brainstem—Parkinson's disease	0.000307	0.0029	CbGeAlD
Ziprasidone—CYP2D6—hindbrain—Parkinson's disease	0.000305	0.00287	CbGeAlD
Ziprasidone—Aripiprazole—HTR7—Parkinson's disease	0.000303	0.0431	CrCbGaD
Ziprasidone—CHRM5—nervous system—Parkinson's disease	0.000303	0.00285	CbGeAlD
Ziprasidone—HTR7—forebrain—Parkinson's disease	0.000297	0.00279	CbGeAlD
Ziprasidone—ADRA1A—brainstem—Parkinson's disease	0.000297	0.00279	CbGeAlD
Ziprasidone—CHRM4—brain—Parkinson's disease	0.000296	0.00279	CbGeAlD
Ziprasidone—CHRM1—cardiovascular system—Parkinson's disease	0.000295	0.00277	CbGeAlD
Ziprasidone—ADRA1B—head—Parkinson's disease	0.000292	0.00275	CbGeAlD
Ziprasidone—CHRM5—central nervous system—Parkinson's disease	0.000291	0.00274	CbGeAlD
Ziprasidone—DRD2—brainstem—Parkinson's disease	0.000291	0.00274	CbGeAlD
Ziprasidone—ADRA1A—forebrain—Parkinson's disease	0.000286	0.0027	CbGeAlD
Ziprasidone—Aripiprazole—DRD3—Parkinson's disease	0.000285	0.0405	CrCbGaD
Ziprasidone—DRD2—forebrain—Parkinson's disease	0.000281	0.00264	CbGeAlD
Ziprasidone—Aripiprazole—DRD1—Parkinson's disease	0.00028	0.0398	CrCbGaD
Ziprasidone—ADRA1B—nervous system—Parkinson's disease	0.000277	0.0026	CbGeAlD
Ziprasidone—KCNH2—forebrain—Parkinson's disease	0.000276	0.0026	CbGeAlD
Ziprasidone—H1F0—head—Parkinson's disease	0.000275	0.00259	CbGeAlD
Ziprasidone—DRD3—brain—Parkinson's disease	0.000275	0.00259	CbGeAlD
Ziprasidone—DRD1—head—Parkinson's disease	0.000272	0.00256	CbGeAlD
Ziprasidone—HTR2C—medulla oblongata—Parkinson's disease	0.000266	0.00251	CbGeAlD
Ziprasidone—ADRA1B—central nervous system—Parkinson's disease	0.000266	0.00251	CbGeAlD
Ziprasidone—HTR6—brain—Parkinson's disease	0.000265	0.00249	CbGeAlD
Ziprasidone—HTR3A—head—Parkinson's disease	0.000263	0.00247	CbGeAlD
Ziprasidone—HTR1A—cardiovascular system—Parkinson's disease	0.000263	0.00247	CbGeAlD
Ziprasidone—H1F0—nervous system—Parkinson's disease	0.000261	0.00246	CbGeAlD
Ziprasidone—DRD5—brain—Parkinson's disease	0.000258	0.00243	CbGeAlD
Ziprasidone—DRD1—nervous system—Parkinson's disease	0.000258	0.00243	CbGeAlD
Ziprasidone—HTR1B—midbrain—Parkinson's disease	0.000254	0.00239	CbGeAlD
Ziprasidone—H1F0—central nervous system—Parkinson's disease	0.000251	0.00237	CbGeAlD
Ziprasidone—HTR7—cardiovascular system—Parkinson's disease	0.000251	0.00236	CbGeAlD
Ziprasidone—HTR3A—nervous system—Parkinson's disease	0.000249	0.00234	CbGeAlD
Ziprasidone—DRD1—central nervous system—Parkinson's disease	0.000248	0.00234	CbGeAlD
Ziprasidone—HTR1B—spinal cord—Parkinson's disease	0.000248	0.00233	CbGeAlD
Ziprasidone—HTR1D—midbrain—Parkinson's disease	0.000246	0.00232	CbGeAlD
Ziprasidone—H1F0—cerebellum—Parkinson's disease	0.000246	0.00231	CbGeAlD
Ziprasidone—HTR2C—midbrain—Parkinson's disease	0.000244	0.00229	CbGeAlD
Ziprasidone—ADRA1A—cardiovascular system—Parkinson's disease	0.000242	0.00228	CbGeAlD
Ziprasidone—HTR3A—central nervous system—Parkinson's disease	0.00024	0.00226	CbGeAlD
Ziprasidone—HTR2C—spinal cord—Parkinson's disease	0.000238	0.00224	CbGeAlD
Ziprasidone—KCNH2—cardiovascular system—Parkinson's disease	0.000234	0.0022	CbGeAlD
Ziprasidone—Aripiprazole—HTR1A—Parkinson's disease	0.000232	0.033	CrCbGaD
Ziprasidone—CHRM5—brain—Parkinson's disease	0.000231	0.00218	CbGeAlD
Ziprasidone—Trazodone—HTR1A—Parkinson's disease	0.000231	0.0329	CrCbGaD
Ziprasidone—SLC6A4—midbrain—Parkinson's disease	0.000231	0.00217	CbGeAlD
Ziprasidone—SLC6A4—spinal cord—Parkinson's disease	0.000225	0.00212	CbGeAlD
Ziprasidone—HRH1—forebrain—Parkinson's disease	0.000222	0.00209	CbGeAlD
Ziprasidone—HTR1B—head—Parkinson's disease	0.00022	0.00207	CbGeAlD
Ziprasidone—CHRM2—head—Parkinson's disease	0.000219	0.00206	CbGeAlD
Ziprasidone—ADRA2A—forebrain—Parkinson's disease	0.000218	0.00205	CbGeAlD
Ziprasidone—HTR7—medulla oblongata—Parkinson's disease	0.000214	0.00202	CbGeAlD
Ziprasidone—HTR1D—head—Parkinson's disease	0.000213	0.00201	CbGeAlD
Ziprasidone—ADRA1B—brain—Parkinson's disease	0.000211	0.00199	CbGeAlD
Ziprasidone—HTR2C—head—Parkinson's disease	0.000211	0.00199	CbGeAlD
Ziprasidone—HTR2A—embryo—Parkinson's disease	0.000209	0.00197	CbGeAlD
Ziprasidone—HTR1B—nervous system—Parkinson's disease	0.000209	0.00197	CbGeAlD
Ziprasidone—CHRM2—nervous system—Parkinson's disease	0.000208	0.00196	CbGeAlD
Ziprasidone—HTR1A—midbrain—Parkinson's disease	0.000205	0.00193	CbGeAlD
Ziprasidone—HTR1D—nervous system—Parkinson's disease	0.000202	0.0019	CbGeAlD
Ziprasidone—HTR1B—central nervous system—Parkinson's disease	0.000201	0.00189	CbGeAlD
Ziprasidone—HTR2C—nervous system—Parkinson's disease	0.0002	0.00189	CbGeAlD
Ziprasidone—SLC6A4—head—Parkinson's disease	0.0002	0.00189	CbGeAlD
Ziprasidone—HTR1A—spinal cord—Parkinson's disease	0.0002	0.00188	CbGeAlD
Ziprasidone—CHRM2—central nervous system—Parkinson's disease	0.0002	0.00188	CbGeAlD
Ziprasidone—KCNH2—medulla oblongata—Parkinson's disease	0.0002	0.00188	CbGeAlD
Ziprasidone—H1F0—brain—Parkinson's disease	0.0002	0.00188	CbGeAlD
Ziprasidone—CHRM1—head—Parkinson's disease	0.000199	0.00188	CbGeAlD
Ziprasidone—Aripiprazole—DRD2—Parkinson's disease	0.000197	0.0281	CrCbGaD
Ziprasidone—ADRA2C—medulla oblongata—Parkinson's disease	0.000197	0.00186	CbGeAlD
Ziprasidone—DRD1—brain—Parkinson's disease	0.000197	0.00186	CbGeAlD
Ziprasidone—HTR7—midbrain—Parkinson's disease	0.000196	0.00185	CbGeAlD
Ziprasidone—HTR1D—central nervous system—Parkinson's disease	0.000195	0.00183	CbGeAlD
Ziprasidone—HTR2C—central nervous system—Parkinson's disease	0.000193	0.00182	CbGeAlD
Ziprasidone—HTR2A—brainstem—Parkinson's disease	0.000192	0.00181	CbGeAlD
Ziprasidone—HTR7—spinal cord—Parkinson's disease	0.000191	0.0018	CbGeAlD
Ziprasidone—HTR3A—brain—Parkinson's disease	0.00019	0.00179	CbGeAlD
Ziprasidone—SLC6A4—nervous system—Parkinson's disease	0.00019	0.00179	CbGeAlD
Ziprasidone—CHRM1—nervous system—Parkinson's disease	0.000189	0.00178	CbGeAlD
Ziprasidone—DRD2—midbrain—Parkinson's disease	0.000185	0.00174	CbGeAlD
Ziprasidone—HTR2A—forebrain—Parkinson's disease	0.000185	0.00174	CbGeAlD
Ziprasidone—SLC6A4—central nervous system—Parkinson's disease	0.000183	0.00172	CbGeAlD
Ziprasidone—KCNH2—midbrain—Parkinson's disease	0.000183	0.00172	CbGeAlD
Ziprasidone—CHRM1—central nervous system—Parkinson's disease	0.000182	0.00171	CbGeAlD
Ziprasidone—ADRA2C—midbrain—Parkinson's disease	0.00018	0.0017	CbGeAlD
Ziprasidone—CHRM3—head—Parkinson's disease	0.000178	0.00168	CbGeAlD
Ziprasidone—KCNH2—spinal cord—Parkinson's disease	0.000178	0.00168	CbGeAlD
Ziprasidone—HTR1A—head—Parkinson's disease	0.000178	0.00167	CbGeAlD
Ziprasidone—ADRA2C—spinal cord—Parkinson's disease	0.000176	0.00165	CbGeAlD
Ziprasidone—CYP2D6—brainstem—Parkinson's disease	0.000175	0.00164	CbGeAlD
Ziprasidone—HTR7—head—Parkinson's disease	0.00017	0.0016	CbGeAlD
Ziprasidone—CHRM3—nervous system—Parkinson's disease	0.000169	0.00159	CbGeAlD
Ziprasidone—CYP2D6—forebrain—Parkinson's disease	0.000169	0.00159	CbGeAlD
Ziprasidone—HTR1A—nervous system—Parkinson's disease	0.000169	0.00159	CbGeAlD
Ziprasidone—ADRA1A—head—Parkinson's disease	0.000164	0.00154	CbGeAlD
Ziprasidone—CHRM3—central nervous system—Parkinson's disease	0.000163	0.00153	CbGeAlD
Ziprasidone—Clozapine—HTR7—Parkinson's disease	0.000163	0.0232	CrCbGaD
Ziprasidone—HTR1A—central nervous system—Parkinson's disease	0.000162	0.00153	CbGeAlD
Ziprasidone—HTR7—nervous system—Parkinson's disease	0.000161	0.00152	CbGeAlD
Ziprasidone—DRD2—head—Parkinson's disease	0.000161	0.00151	CbGeAlD
Ziprasidone—HTR1B—brain—Parkinson's disease	0.00016	0.0015	CbGeAlD
Ziprasidone—CHRM2—brain—Parkinson's disease	0.000159	0.0015	CbGeAlD
Ziprasidone—HTR1A—cerebellum—Parkinson's disease	0.000159	0.00149	CbGeAlD
Ziprasidone—KCNH2—head—Parkinson's disease	0.000158	0.00149	CbGeAlD
Ziprasidone—ADRA2A—medulla oblongata—Parkinson's disease	0.000157	0.00148	CbGeAlD
Ziprasidone—HTR2A—cardiovascular system—Parkinson's disease	0.000156	0.00147	CbGeAlD
Ziprasidone—ADRA2C—head—Parkinson's disease	0.000156	0.00147	CbGeAlD
Ziprasidone—ADRA1A—nervous system—Parkinson's disease	0.000155	0.00146	CbGeAlD
Ziprasidone—HTR7—central nervous system—Parkinson's disease	0.000155	0.00146	CbGeAlD
Ziprasidone—HTR1D—brain—Parkinson's disease	0.000155	0.00146	CbGeAlD
Ziprasidone—Clozapine—DRD3—Parkinson's disease	0.000153	0.0218	CrCbGaD
Ziprasidone—HTR2C—brain—Parkinson's disease	0.000153	0.00144	CbGeAlD
Ziprasidone—Aripiprazole—HTR2A—Parkinson's disease	0.000152	0.0217	CrCbGaD
Ziprasidone—DRD2—nervous system—Parkinson's disease	0.000152	0.00143	CbGeAlD
Ziprasidone—Trazodone—HTR2A—Parkinson's disease	0.000152	0.0216	CrCbGaD
Ziprasidone—HTR7—cerebellum—Parkinson's disease	0.000152	0.00143	CbGeAlD
Ziprasidone—Clozapine—DRD1—Parkinson's disease	0.00015	0.0214	CrCbGaD
Ziprasidone—KCNH2—nervous system—Parkinson's disease	0.00015	0.00141	CbGeAlD
Ziprasidone—ADRA1A—central nervous system—Parkinson's disease	0.00015	0.00141	CbGeAlD
Ziprasidone—ADRA2C—nervous system—Parkinson's disease	0.000148	0.00139	CbGeAlD
Ziprasidone—DRD2—central nervous system—Parkinson's disease	0.000147	0.00138	CbGeAlD
Ziprasidone—ADRA1A—cerebellum—Parkinson's disease	0.000146	0.00138	CbGeAlD
Ziprasidone—SLC6A4—brain—Parkinson's disease	0.000145	0.00137	CbGeAlD
Ziprasidone—CHRM1—brain—Parkinson's disease	0.000145	0.00136	CbGeAlD
Ziprasidone—KCNH2—central nervous system—Parkinson's disease	0.000144	0.00136	CbGeAlD
Ziprasidone—ADRA2A—midbrain—Parkinson's disease	0.000144	0.00135	CbGeAlD
Ziprasidone—DRD2—cerebellum—Parkinson's disease	0.000143	0.00135	CbGeAlD
Ziprasidone—ADRA2C—central nervous system—Parkinson's disease	0.000143	0.00134	CbGeAlD
Ziprasidone—KCNH2—cerebellum—Parkinson's disease	0.000141	0.00133	CbGeAlD
Ziprasidone—ADRA2A—spinal cord—Parkinson's disease	0.00014	0.00132	CbGeAlD
Ziprasidone—Aripiprazole—CYP2D6—Parkinson's disease	0.000139	0.0198	CrCbGaD
Ziprasidone—ADRA2C—cerebellum—Parkinson's disease	0.000139	0.00131	CbGeAlD
Ziprasidone—Trazodone—CYP2D6—Parkinson's disease	0.000139	0.0197	CrCbGaD
Ziprasidone—HTR2A—medulla oblongata—Parkinson's disease	0.000134	0.00126	CbGeAlD
Ziprasidone—CHRM3—brain—Parkinson's disease	0.000129	0.00122	CbGeAlD
Ziprasidone—HTR1A—brain—Parkinson's disease	0.000129	0.00121	CbGeAlD
Ziprasidone—HRH1—head—Parkinson's disease	0.000127	0.00119	CbGeAlD
Ziprasidone—Clozapine—HTR1A—Parkinson's disease	0.000125	0.0178	CrCbGaD
Ziprasidone—ADRA2A—head—Parkinson's disease	0.000125	0.00117	CbGeAlD
Ziprasidone—HTR7—brain—Parkinson's disease	0.000123	0.00116	CbGeAlD
Ziprasidone—HTR2A—midbrain—Parkinson's disease	0.000122	0.00115	CbGeAlD
Ziprasidone—HRH1—nervous system—Parkinson's disease	0.00012	0.00113	CbGeAlD
Ziprasidone—HTR2A—spinal cord—Parkinson's disease	0.000119	0.00112	CbGeAlD
Ziprasidone—ADRA1A—brain—Parkinson's disease	0.000119	0.00112	CbGeAlD
Ziprasidone—ADRA2A—nervous system—Parkinson's disease	0.000118	0.00111	CbGeAlD
Ziprasidone—DRD2—brain—Parkinson's disease	0.000116	0.0011	CbGeAlD
Ziprasidone—HRH1—central nervous system—Parkinson's disease	0.000116	0.00109	CbGeAlD
Ziprasidone—KCNH2—brain—Parkinson's disease	0.000115	0.00108	CbGeAlD
Ziprasidone—ADRA2A—central nervous system—Parkinson's disease	0.000114	0.00107	CbGeAlD
Ziprasidone—ADRA2C—brain—Parkinson's disease	0.000113	0.00107	CbGeAlD
Ziprasidone—ADRA2A—cerebellum—Parkinson's disease	0.000111	0.00105	CbGeAlD
Ziprasidone—Clozapine—DRD2—Parkinson's disease	0.000106	0.0151	CrCbGaD
Ziprasidone—HTR2A—head—Parkinson's disease	0.000106	0.000998	CbGeAlD
Ziprasidone—Clozapine—CYP2E1—Parkinson's disease	0.000102	0.0145	CrCbGaD
Ziprasidone—HTR2A—nervous system—Parkinson's disease	0.0001	0.000946	CbGeAlD
Ziprasidone—Aripiprazole—ABCB1—Parkinson's disease	9.95e-05	0.0142	CrCbGaD
Ziprasidone—Trazodone—ABCB1—Parkinson's disease	9.9e-05	0.0141	CrCbGaD
Ziprasidone—HTR2A—central nervous system—Parkinson's disease	9.67e-05	0.000911	CbGeAlD
Ziprasidone—CYP2D6—head—Parkinson's disease	9.65e-05	0.000909	CbGeAlD
Ziprasidone—HTR2A—cerebellum—Parkinson's disease	9.45e-05	0.00089	CbGeAlD
Ziprasidone—CYP3A4—nervous system—Parkinson's disease	9.3e-05	0.000876	CbGeAlD
Ziprasidone—HRH1—brain—Parkinson's disease	9.19e-05	0.000866	CbGeAlD
Ziprasidone—CYP2D6—nervous system—Parkinson's disease	9.15e-05	0.000862	CbGeAlD
Ziprasidone—ADRA2A—brain—Parkinson's disease	9.03e-05	0.00085	CbGeAlD
Ziprasidone—CYP3A4—central nervous system—Parkinson's disease	8.95e-05	0.000843	CbGeAlD
Ziprasidone—CYP2D6—central nervous system—Parkinson's disease	8.81e-05	0.00083	CbGeAlD
Ziprasidone—CYP2D6—cerebellum—Parkinson's disease	8.61e-05	0.000811	CbGeAlD
Ziprasidone—Clozapine—HTR2A—Parkinson's disease	8.19e-05	0.0117	CrCbGaD
Ziprasidone—HTR2A—brain—Parkinson's disease	7.68e-05	0.000723	CbGeAlD
Ziprasidone—Clozapine—CYP2D6—Parkinson's disease	7.49e-05	0.0107	CrCbGaD
Ziprasidone—CYP2D6—brain—Parkinson's disease	6.99e-05	0.000659	CbGeAlD
Ziprasidone—Clozapine—ABCB1—Parkinson's disease	5.35e-05	0.00761	CrCbGaD
Ziprasidone—ADRA2C—Metabolism—APOE—Parkinson's disease	4.06e-06	2.55e-05	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—MAPK8—Parkinson's disease	4.06e-06	2.55e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—INS—Parkinson's disease	4.05e-06	2.54e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—INS—Parkinson's disease	4.05e-06	2.54e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—APOE—Parkinson's disease	4.03e-06	2.53e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—INS—Parkinson's disease	4.02e-06	2.52e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—COMT—Parkinson's disease	4.02e-06	2.52e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—GSTM1—Parkinson's disease	4.01e-06	2.52e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—GSTP1—Parkinson's disease	4e-06	2.51e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—MAOA—Parkinson's disease	3.99e-06	2.5e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IGF2—Parkinson's disease	3.97e-06	2.49e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—NGF—Parkinson's disease	3.97e-06	2.49e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—NGF—Parkinson's disease	3.95e-06	2.48e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—HMOX1—Parkinson's disease	3.94e-06	2.47e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—DDC—Parkinson's disease	3.94e-06	2.47e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—INS—Parkinson's disease	3.94e-06	2.47e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—HTR2A—Parkinson's disease	3.91e-06	2.45e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—CASP3—Parkinson's disease	3.91e-06	2.45e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	3.9e-06	2.45e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IGF2—Parkinson's disease	3.89e-06	2.44e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling by GPCR—IL6—Parkinson's disease	3.88e-06	2.44e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	3.88e-06	2.44e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—INS—Parkinson's disease	3.87e-06	2.43e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	3.87e-06	2.43e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—MTHFR—Parkinson's disease	3.86e-06	2.42e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—GPX1—Parkinson's disease	3.84e-06	2.41e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—NGF—Parkinson's disease	3.84e-06	2.41e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	3.84e-06	2.41e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	3.83e-06	2.4e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	3.82e-06	2.4e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—INS—Parkinson's disease	3.82e-06	2.4e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—EDN1—Parkinson's disease	3.79e-06	2.38e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—ABCB1—Parkinson's disease	3.79e-06	2.37e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	3.78e-06	2.37e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	3.78e-06	2.37e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	3.77e-06	2.37e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	3.77e-06	2.36e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	3.76e-06	2.36e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	3.75e-06	2.35e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	3.74e-06	2.35e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	3.73e-06	2.34e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GSTA4—Parkinson's disease	3.72e-06	2.33e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—EDN1—Parkinson's disease	3.72e-06	2.33e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	3.71e-06	2.33e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	3.71e-06	2.32e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—CTGF—Parkinson's disease	3.7e-06	2.32e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	3.7e-06	2.32e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	3.7e-06	2.32e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—GSTM1—Parkinson's disease	3.68e-06	2.31e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	3.66e-06	2.3e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—INS—Parkinson's disease	3.66e-06	2.3e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—HTR2A—Parkinson's disease	3.65e-06	2.29e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	3.65e-06	2.29e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—APOE—Parkinson's disease	3.64e-06	2.28e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	3.6e-06	2.26e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—APOE—Parkinson's disease	3.6e-06	2.26e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—MAPK8—Parkinson's disease	3.59e-06	2.25e-05	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—INS—Parkinson's disease	3.57e-06	2.24e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	3.55e-06	2.23e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—MTHFR—Parkinson's disease	3.54e-06	2.22e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—GPX1—Parkinson's disease	3.52e-06	2.21e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—APOE—Parkinson's disease	3.51e-06	2.2e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—APOE—Parkinson's disease	3.49e-06	2.19e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—INS—Parkinson's disease	3.49e-06	2.19e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—NGF—Parkinson's disease	3.48e-06	2.18e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—INS—Parkinson's disease	3.47e-06	2.18e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	3.45e-06	2.16e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—INS—Parkinson's disease	3.44e-06	2.16e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	3.43e-06	2.15e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—NGF—Parkinson's disease	3.43e-06	2.15e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—NGF—Parkinson's disease	3.42e-06	2.15e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—NQO1—Parkinson's disease	3.41e-06	2.14e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—NGF—Parkinson's disease	3.41e-06	2.14e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—NGF—Parkinson's disease	3.4e-06	2.13e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—APOE—Parkinson's disease	3.4e-06	2.13e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	3.39e-06	2.13e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—NGF—Parkinson's disease	3.36e-06	2.11e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—TH—Parkinson's disease	3.36e-06	2.11e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	3.36e-06	2.1e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	3.35e-06	2.1e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	3.34e-06	2.1e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—MAOB—Parkinson's disease	3.32e-06	2.08e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	3.32e-06	2.08e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—APOE—Parkinson's disease	3.3e-06	2.07e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	3.26e-06	2.04e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—MTHFR—Parkinson's disease	3.25e-06	2.04e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	3.24e-06	2.04e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	3.23e-06	2.03e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—CYCS—Parkinson's disease	3.23e-06	2.02e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	3.2e-06	2.01e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	3.19e-06	2e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	3.19e-06	2e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CTGF—Parkinson's disease	3.14e-06	1.97e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	3.12e-06	1.96e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—INS—Parkinson's disease	3.11e-06	1.95e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—APOE—Parkinson's disease	3.08e-06	1.93e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—INS—Parkinson's disease	3.07e-06	1.93e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—APOE—Parkinson's disease	3.03e-06	1.9e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—APOE—Parkinson's disease	3.03e-06	1.9e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—APOE—Parkinson's disease	3.02e-06	1.9e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—APOE—Parkinson's disease	3.02e-06	1.89e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—CASP3—Parkinson's disease	3.02e-06	1.89e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—CASP3—Parkinson's disease	3.01e-06	1.89e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—APOE—Parkinson's disease	3.01e-06	1.89e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—INS—Parkinson's disease	3e-06	1.88e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling by GPCR—IL6—Parkinson's disease	3e-06	1.88e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling by GPCR—IL6—Parkinson's disease	2.99e-06	1.88e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	2.99e-06	1.88e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—INS—Parkinson's disease	2.98e-06	1.87e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—APOE—Parkinson's disease	2.98e-06	1.87e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	2.97e-06	1.87e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	2.97e-06	1.86e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	2.97e-06	1.86e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	2.93e-06	1.84e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	2.92e-06	1.83e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	2.91e-06	1.83e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—INS—Parkinson's disease	2.9e-06	1.82e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—NQO1—Parkinson's disease	2.89e-06	1.81e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—CASP3—Parkinson's disease	2.88e-06	1.81e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling by GPCR—IL6—Parkinson's disease	2.87e-06	1.8e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—COMT—Parkinson's disease	2.86e-06	1.79e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—INS—Parkinson's disease	2.86e-06	1.79e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—TH—Parkinson's disease	2.85e-06	1.79e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—CASP3—Parkinson's disease	2.85e-06	1.79e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—GSTP1—Parkinson's disease	2.84e-06	1.78e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—MAOA—Parkinson's disease	2.84e-06	1.78e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling by GPCR—IL6—Parkinson's disease	2.83e-06	1.77e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—INS—Parkinson's disease	2.82e-06	1.77e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—HMOX1—Parkinson's disease	2.8e-06	1.76e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—MAPK8—Parkinson's disease	2.77e-06	1.74e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—MAPK8—Parkinson's disease	2.77e-06	1.74e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	2.76e-06	1.73e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	2.75e-06	1.73e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CYCS—Parkinson's disease	2.73e-06	1.71e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	2.72e-06	1.71e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	2.71e-06	1.7e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	2.69e-06	1.69e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—ABCB1—Parkinson's disease	2.69e-06	1.69e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—MAPK8—Parkinson's disease	2.65e-06	1.66e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—INS—Parkinson's disease	2.63e-06	1.65e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—MAPK8—Parkinson's disease	2.62e-06	1.64e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—GSTM1—Parkinson's disease	2.61e-06	1.64e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—CASP3—Parkinson's disease	2.6e-06	1.63e-05	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—IL6—Parkinson's disease	2.59e-06	1.63e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—INS—Parkinson's disease	2.59e-06	1.63e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—INS—Parkinson's disease	2.59e-06	1.62e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—INS—Parkinson's disease	2.58e-06	1.62e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—IL6—Parkinson's disease	2.58e-06	1.62e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—INS—Parkinson's disease	2.58e-06	1.62e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—INS—Parkinson's disease	2.57e-06	1.61e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—CASP3—Parkinson's disease	2.56e-06	1.61e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—IL6—Parkinson's disease	2.55e-06	1.6e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—INS—Parkinson's disease	2.54e-06	1.6e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—INS—Parkinson's disease	2.54e-06	1.59e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	2.5e-06	1.57e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—GPX1—Parkinson's disease	2.5e-06	1.57e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	2.47e-06	1.55e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—COMT—Parkinson's disease	2.42e-06	1.52e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CTGF—Parkinson's disease	2.42e-06	1.52e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—GSTP1—Parkinson's disease	2.41e-06	1.51e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—MAOA—Parkinson's disease	2.4e-06	1.51e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—MAPK8—Parkinson's disease	2.39e-06	1.5e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—HMOX1—Parkinson's disease	2.38e-06	1.49e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—INS—Parkinson's disease	2.36e-06	1.48e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—MAPK8—Parkinson's disease	2.35e-06	1.48e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CASP3—Parkinson's disease	2.31e-06	1.45e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—MTHFR—Parkinson's disease	2.31e-06	1.45e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—IL6—Parkinson's disease	2.3e-06	1.44e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—IL6—Parkinson's disease	2.29e-06	1.44e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—ABCB1—Parkinson's disease	2.28e-06	1.43e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	2.25e-06	1.41e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	2.23e-06	1.4e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—NQO1—Parkinson's disease	2.23e-06	1.4e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	2.22e-06	1.39e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	2.22e-06	1.39e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—GSTM1—Parkinson's disease	2.21e-06	1.39e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	2.21e-06	1.38e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—TH—Parkinson's disease	2.2e-06	1.38e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CASP3—Parkinson's disease	2.16e-06	1.36e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—APOE—Parkinson's disease	2.15e-06	1.35e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—IL6—Parkinson's disease	2.15e-06	1.35e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	2.13e-06	1.33e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—MAPK8—Parkinson's disease	2.13e-06	1.33e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—GPX1—Parkinson's disease	2.12e-06	1.33e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	2.11e-06	1.33e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CYCS—Parkinson's disease	2.11e-06	1.32e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	2.05e-06	1.29e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	2.04e-06	1.28e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MAPK8—Parkinson's disease	1.99e-06	1.25e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CASP3—Parkinson's disease	1.96e-06	1.23e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—MTHFR—Parkinson's disease	1.96e-06	1.23e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	1.95e-06	1.23e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—IL6—Parkinson's disease	1.95e-06	1.22e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	1.93e-06	1.21e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CASP3—Parkinson's disease	1.92e-06	1.21e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	1.92e-06	1.2e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	1.92e-06	1.2e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	1.91e-06	1.2e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—IL6—Parkinson's disease	1.91e-06	1.2e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	1.91e-06	1.2e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	1.9e-06	1.19e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	1.89e-06	1.19e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	1.89e-06	1.18e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	1.88e-06	1.18e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	1.88e-06	1.18e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—COMT—Parkinson's disease	1.87e-06	1.17e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.86e-06	1.17e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.85e-06	1.16e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—INS—Parkinson's disease	1.84e-06	1.15e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.83e-06	1.15e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—APOE—Parkinson's disease	1.82e-06	1.14e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	1.8e-06	1.13e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	1.77e-06	1.11e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—IL6—Parkinson's disease	1.77e-06	1.11e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	1.77e-06	1.11e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—IL6—Parkinson's disease	1.77e-06	1.11e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	1.76e-06	1.11e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.76e-06	1.1e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	1.76e-06	1.1e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—IL6—Parkinson's disease	1.76e-06	1.1e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	1.75e-06	1.1e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	1.74e-06	1.09e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	1.74e-06	1.09e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	1.74e-06	1.09e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—IL6—Parkinson's disease	1.72e-06	1.08e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.71e-06	1.07e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—IL6—Parkinson's disease	1.69e-06	1.06e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—IL6—Parkinson's disease	1.67e-06	1.05e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.64e-06	1.03e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	1.61e-06	1.01e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—IL6—Parkinson's disease	1.6e-06	1e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—INS—Parkinson's disease	1.56e-06	9.76e-06	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—IL6—Parkinson's disease	1.52e-06	9.56e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.51e-06	9.47e-06	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—IL6—Parkinson's disease	1.5e-06	9.43e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—APOE—Parkinson's disease	1.41e-06	8.82e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IL6—Parkinson's disease	1.36e-06	8.52e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IL6—Parkinson's disease	1.31e-06	8.22e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IL6—Parkinson's disease	1.3e-06	8.18e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IL6—Parkinson's disease	1.27e-06	7.95e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	1.25e-06	7.83e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—INS—Parkinson's disease	1.2e-06	7.53e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL6—Parkinson's disease	1.15e-06	7.22e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL6—Parkinson's disease	1.13e-06	7.1e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL6—Parkinson's disease	1.13e-06	7.09e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL6—Parkinson's disease	1.13e-06	7.06e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL6—Parkinson's disease	1.12e-06	7.04e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL6—Parkinson's disease	1.11e-06	6.97e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	1.11e-06	6.95e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	1.03e-06	6.46e-06	CbGpPWpGaD
